glp 1 medications near me GLP-1 Weight Loss | Semaglutide & Tirzepatide GLP-1 Medications: The Good, The

But, anyone who has neovascular AMD and is on a GLP-1 needs to be monitored more closely, said Lam

Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)

doi: 10.1097/prs.0000000000007783 7 SchaverienMVAsaadMSelberJCLiuJChenDNHallMSet al

25STCV04635, California state court Los Angeles (Feb

Annu Rev Pathol

Phase 3 trial results have been recently published for the first pills and they are quite promising